309 results on '"Sorce, Gabriele"'
Search Results
2. Does previous transurethral resection of the prostate affect the outcomes in robotic assisted radical prostatectomy?
3. Transitioning from Da Vinci Si to Xi: assessing surgical outcomes at a high-volume robotic center
4. In-Hospital Venous Thromboembolism and Pulmonary Embolism After Major Urologic Cancer Surgery
5. Evaluation of Clinical Research on Novel Multiport Robotic Platforms for Urological Surgery According to the IDEAL Framework: A Systematic Review of the Literature
6. Impact of prostate MRI central review over the diagnostic performance of MRI-targeted biopsy: should we routinely ask for an expert second opinion?
7. Added Value of Prostate-specific Antigen Density in Selecting Prostate Biopsy Candidates Among Men with Elevated Prostate-specific Antigen and PI-RADS ≥3 Lesions on Multiparametric Magnetic Resonance Imaging of the Prostate: A Systematic Assessment by PI-RADS Score
8. Robot-assisted Radical Prostatectomy Performed with Different Robotic Platforms: First Comparative Evidence Between Da Vinci and HUGO Robot-assisted Surgery Robots
9. ASO Visual Abstract: In-Hospital Venous Thromboembolism and Pulmonary Embolism After Major Urological Cancer Surgery
10. Regional differences in total hospital costs for radical cystectomy in the United States
11. Contemporary vs historical survival rates in metastatic clear cell renal carcinoma according to race/ethnicity
12. Mortality According to Treatment in Metastatic Collecting Duct Renal Cell Carcinoma
13. Cancer specific mortality in patients with collecting duct vs. clear cell renal carcinoma
14. Cancer-specific Mortality in T1a Renal Cell Carcinoma Treated with Local Tumor Destruction Versus Partial Nephrectomy
15. Adverse upgrading and/or upstaging in contemporary low-risk prostate cancer patients
16. Effect of Inferior Vena Cava Tumor Thrombus on Overall Survival in Metastatic Renal Cell Carcinoma Patients Treated with Cytoreductive Nephrectomy
17. Contemporary Pathological Stage Distribution After Radical Prostatectomy in North American High-Risk Prostate Cancer Patients
18. IO-IO vs IO-TKI efficacy in metastatic kidney cancer patients: A structured systematic review over time
19. Life expectancy in metastatic urothelial bladder cancer patients according to race/ethnicity
20. Plasmacytoid variant urothelial carcinoma of the bladder: effect of radical cystectomy and chemotherapy in non-metastatic and metastatic patients
21. Metastatic stage vs complications at radical nephrectomy with inferior vena cava thrombectomy
22. Cancer-specific mortality in patients with non-metastatic renal cell carcinoma who have undergone a nephrectomy and are eligible for adjuvant pembrolizumab
23. Up- and downgrading in single intermediate-risk positive biopsy core prostate cancer
24. Cancer-specific mortality after radical prostatectomy vs external beam radiotherapy in high-risk Hispanic/Latino prostate cancer patients
25. Survival after radical prostatectomy vs. radiation therapy in ductal carcinoma of the prostate
26. Optimizing prostate-targeted biopsy schemes in men with multiple mpMRI visible lesions: should we target all suspicious areas? Results of a two institution series
27. Balancing oncological control and renal function: the emerging role of robotic distal ureterectomy in upper tract urothelial carcinoma.
28. MP19-07 TOWARDS A TAILORED USE OF PSA DENSITY TO DECIDE WHEN TO AVOID PROSTATE BIOPSY IN MEN WITH PIRADS 3 LESIONS ACCORDING TO THE LOCATION OF THE INDEX LESION AT MP-MRI. RESULTS OF A LARGE, MULTI-INSTITUTIONAL SERIES
29. PD50-09 A NOMOGRAM TO PREDICT LYMPHNODE INVOLVEMENT IN CANDIDATES TO ROBOT-ASSISTED RADICAL PROSTATECTOMY WITH IT3 PROSTATE CANCER ON PREOPERATIVE MULTIPARAMETRIC MRI AS UNIQUE HIGH-RISK FEATURE
30. PD45-05 WHEN DOES SYSTEMATIC BIOPSY INFORMATION MATTER THE MOST? IDENTIFYING INDEPENDENT PREDICTORS OF DISEASE DOWNGRADING AT RADICAL PROSTATECTOMY IN HIGH GRADE PROSTATE CANCER BASED ON A LARGE MULTI-INSTITUTIONAL SERIES
31. PD09-03 ASSESSING EPIGENETIC FEATURES ASSOCIATED WITH LYMPH NODE METASTASES IN PROSTATE CANCER
32. MP73-11 TRAIN THE TRAINERS FOR THE DELIVERY OF PROFICIENCY BASED PROGRESSION TRAINING BY THE EUROPEAN ROBOTIC SURGICAL SECTION FELLOWSHIP CENTERS
33. MP37-20 THE EFFECT OF PENILE REHABILITATION AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY ON URINARY CONTINENCE AND ERECTILE FUNCTION RECOVERY. RESULTS FROM a HIGH-VOLUME, SINGLE-SURGEON SERIES
34. Impact of the time elapsed between prostate biopsy and surgery on the accuracy of nomograms predicting lymph node invasion in patients with clinically localized prostate cancer
35. The association of type and number of high-risk criteria with cancer-specific mortality in prostate cancer patients treated with radical prostatectomy.
36. Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer
37. Other-cause mortality and access to care in metastatic renal cell carcinoma according to race/ethnicity
38. Treatment patterns and rates of upgrading and upstaging in prostate cancer patients with single GGG1 positive biopsy core
39. Survival trends in chemotherapy exposed metastatic bladder cancer patients and chemotherapy effect across different age, sex, and race/ethnicity
40. Survival benefit of chemotherapy in a contemporary cohort of metastatic urachal carcinoma
41. How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series
42. Radical Cystectomy vs. Radiotherapy in Urothelial Bladder Cancer in Elderly and Very Elderly Patients
43. Re: Unilateral Pelvic Lymph Node Dissection in Prostate Cancer Patients Diagnosed in the Era of Magnetic Resonance Imaging-targeted Biopsy: A Study that Challenges the Dogma
44. Initial Experience of Robot-Assisted Simple Prostatectomy with Hugo Robot-Assisted Surgery System: Step-by-Step Description of Two Different Techniques
45. Urological surgery with the Hugo RAS™ System: insights into system adaptability.
46. Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer.
47. Robot-Assisted Pyeloplasty with HUGO™ Robotic System: Initial Experience and Optimal Surgical Set-Up at a Tertiary Referral Robotic Center.
48. Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era?
49. ASO visual abstract: in-hospital venous thromboembolism and pulmonary embolism after major urological cancer surgery
50. A comparative analysis of the HUGOTM robot‐assisted surgery system and the Da Vinci® Xi surgical system for robot‐assisted sacrocolpopexy for pelvic organ prolapse treatment.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.